|
|
Article: Report from Europe.
- Article from:
- Medical Device Daily
- Article date:
- February 14, 2007
CopyrightCOPYRIGHT 2007 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Report from Europe
Innocoll receives approval in Germany for new insert size
A Medical Device Daily Staff Report
Innocoll (Ashburn, Virginia) said its sales and marketing subsidiary, Innocoll Pharmaceuticals (Athlone, Ireland), has received approval from the Federal Institute for Drugs and Medical Devices in Germany for marketing a new version of its CollaRx Gentamicin Surgical Implant in that country.
The implant, sold in Germany under the trade name Sulmycin Implant E, previously was available in 10 cm x 10 cm and 5 cm x 5 cm sizes. The new version is 20 cm x 5 cm, and according to Innocoll is the only product of its type available ...
Related newspaper, magazine, and journal articles:
|
|
Article: VP22-mediated trafficking leads to heightened apoptosis in ...
Cancer Weekly;
June 18, 2002 ;
700+ words
... ... expression in primary liver cancer cells. The results of a study that was conducted in Germany has confirmed that VP22 ... a primary form of liver cancer. For a study incorporating ... Hannover, Hannover, Germany, constructed expression ...
|
|